Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
250.94
-6.47 (-2.51%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,258,178
Open
252.54
Bid (Size)
251.40 (100)
Ask (Size)
252.00 (100)
Prev. Close
257.41
Today's Range
247.00 - 255.52
52wk Range
187.62 - 267.47
Shares Outstanding
N/A
Dividend Yield
2.76%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why AbbVie Stock Slumped Today
↗
July 31, 2026
The company, one of the rare healthcare sector Dividend Kings, wasn't looking too royal on the last trading day of the week.
Via
The Motley Fool
Topics
Earnings
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
July 31, 2026
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.65% on an annualized basis producing an average annual return of 16.8%. Currently, AbbVie has a market capitalization of...
Via
Benzinga
Performance
YTD
+9.4%
+9.4%
1 Month
-0.0%
-0.0%
3 Month
+21.5%
+21.5%
6 Month
+12.5%
+12.5%
1 Year
+32.8%
+32.8%
More News
Read More
AbbVie Q2 Earnings Call Highlights
↗
July 31, 2026
Via
MarketBeat
Topics
ETFs
Earnings
AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat
↗
July 31, 2026
Via
Benzinga
AbbVie (NYSE:ABBV) Shares Slip on Apogee Acquisition Despite In-Line Q2 Results
↗
July 31, 2026
Via
Chartmill
Cannabis Theme's Hidden Strength: Established Players Outshining Pure Plays
↗
July 30, 2026
Via
Chartmill
Topics
Cannabis
AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue
July 31, 2026
Via
StockStory
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
↗
July 31, 2026
Via
Chartmill
What To Expect From AbbVie’s (ABBV) Q2 Earnings
July 29, 2026
Via
StockStory
Topics
Artificial Intelligence
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
↗
July 29, 2026
Via
The Motley Fool
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
↗
July 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy AbbVie Stock Hand Over Fist Before July 31?
↗
July 27, 2026
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
↗
July 26, 2026
Via
The Motley Fool
Why Wall Street Can't Get Enough of This Dividend King
↗
July 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
↗
July 24, 2026
Via
The Motley Fool
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
July 23, 2026
From
Genmab A/S and AbbVie
Via
Business Wire
I'd Double a Position in These 3 Dividend Stocks Right Now Without Any Hesitation
↗
July 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
↗
July 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
PJP vs. IYH: Which Healthcare ETF Is the Better Buy?
↗
July 20, 2026
Via
The Motley Fool
Topics
ETFs
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
↗
July 19, 2026
Via
The Motley Fool
My 2 Favorite Dividend Kings to Buy Right Now
↗
July 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
↗
July 17, 2026
Via
Benzinga
3 Rock-Solid Dividend Stocks to Buy and Hold for Decades
↗
July 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
↗
July 14, 2026
Via
The Motley Fool
Topics
Government
Intellectual Property
3 Dividend Stocks Built for Long-Term Buy-and-Hold Investors
↗
July 13, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 250.94
When was AbbVie last traded?
The last trade of AbbVie was at 07/31/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.